Stock Updates

Today’s Top Gainers in the Market Allergan plc (NYSE:AGN) from Healthcare

Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining 1.26% today. In the last week its performance is 2.60%, and 12.86% for the past quarter. Currently, Allergan plc, AGN has a target price of 293.06, so today’s gain of 1.26% is a significant step towards its target price. The GAP today is therefore 1.00%.

Allergan plc (NYSE:AGN), has a market cap of 95564.26, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 89.80%.

At the current price of 244.21, it has a dividend yield of 0.08%, and its target price is 293.06. This is with a profit margin of *TBA, and total debt/equity of 0.59. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 14.09.

With a current EPS of -5.63, and a forecasted EPS growth for next year at 21.95%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 9.70%.

Performance for the year is -23.72%. Since its IPO date on 2/17/1993, the total performance to date is -21.85%.

Volume today for Allergan plc (NYSE:AGN), is 2134800, while its average volume is 3720.89. Whilst the total gain today was 1.26%, it did have a day high of -2.79%.

Volatility for this week has been at 1.92%, and 2.42% for the month. The 52-week low for Allergan plc, AGN has been 24.92%, while the 52-week-high has reached -28.25%.

Looking at its return of investments, which is -1.30%, and its return on assets is *TBA. Allergan plc (NYSE:AGN) has an operating margin of *TBA. With a sales growth of 48.10% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.53, and has a current ratio of 1 and 0.9 for quick ratio.

So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 5.86, along with a P/B of 1.33. Meanwhile it has a p/cash of 42.03.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment